Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cabotegravir sodium is a potent inhibitor of HIV integrase and is able to act on HIVADA (IC50: 2.5 nM). cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1 and is less likely to interact with other antiretroviral drugs (ARVs). Antileishmanial agent-12
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | $ 31.00 |
Description | Cabotegravir sodium is a potent inhibitor of HIV integrase and is able to act on HIVADA (IC50: 2.5 nM). cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1 and is less likely to interact with other antiretroviral drugs (ARVs). Antileishmanial agent-12 |
Molecular Weight | 427.34 |
Formula | C19H16F2N3NaO5 |
CAS No. | 1051375-13-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cabotegravir sodium 1051375-13-3 inhibitor inhibit